Sildenafil Tablet, Film Coated
Product Images NDC 50090-5235

14 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-5235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

Sildenafilfigure7 (Sildenafilfigure7)
A vertical bar chart showing percentages of patients reporting improvement by treatment group. The treatments are placebo and Sildenafil citrate tablets at 25 mg, 50 mg, and 100 mg doses. The chart demonstrates increasing improvement percentages with higher Sildenafil doses, ranging from 24% for placebo to 82% for 100 mg tablets.*
FDA Label Image

Label Image (Lbl500905235)

Label Image (Lbl500905235)
Sildenafil 25 mg film-coated tablets packaging label from A-S Medication Solutions. The label shows dosage form as oral tablets, with each film-coated tablet containing 25 mg of sildenafil. The package contains 10 tablets with storage instructions to keep between 68 to 77 degrees Fahrenheit. Manufacturer is Camber Pharma Inc.*
FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

Sildenafilfigure1 (Sildenafilfigure1)
A line graph showing changes in systolic blood pressure (mmHg) over 24 hours post dose, comparing Sildenafil 100 mg and placebo. The x-axis represents time post dose in hours, marked at pre-dose, 4, 8, 12, and 24 hours. The y-axis shows systolic blood pressure changes ranging from -25 to 15 mmHg. Data points for Sildenafil are shown with circles and for placebo with diamonds.*
FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

Sildenafilfigure2 (Sildenafilfigure2)
A line graph comparing the change in a variable (measured in mmHg) over time (hours). The graph features two lines representing the effects of Placebo and Sildenafil 25 mg, showing changes in blood pressure relative to baseline over an 8-hour period.*
FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

Sildenafilfigure3 (Sildenafilfigure3)
A line graph depicting the change in a measured variable over time (hours) postdose. The graph compares two data sets labeled as Doxazosin + Prazosin and Doxazosin + Sildenafil 50 mg, showing their respective trends throughout an 8-hour period.*
FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

Sildenafilfigure4 (Sildenafilfigure4)
A line graph depicting changes over time up to 8 hours after dosing, comparing the effects of Doxazosin plus Sildenafil 100 mg versus Doxazosin plus Placebo. The y-axis represents mmHg, likely indicating blood pressure, with values declining sharply initially and then leveling off, showing data points connected by lines for each treatment group.*
FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

Sildenafilfigure5 (Sildenafilfigure5)
A pharmacokinetic curve showing plasma concentration of a drug in ng/mL over 24 hours post dose. The x-axis represents time in hours, and the y-axis shows plasma concentration. The single plotted line represents the commercial tablet treatment.*
FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

Sildenafilfigure6a (Sildenafilfigure6a)
Bar chart depicting the percentage of patients at endpoint across different baseline scores, with data grouped into six categories represented by bars labeled 0 through 5. The vertical axis shows percentage of patients, and the horizontal axis shows baseline scores ranging from 0 to 5.*
FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart depicting the percentage of patients at endpoint according to baseline score categories ranging from 0 to 5. Multiple data series are shown with varying bar heights for each baseline score, marked by a legend on the right identifying categories labeled 00 through 5.*
FDA Label Image

Sildenafilheterologo1 (Sildenafilheterologo1)

FDA Label Image

Sildenafilheterologo2 (Sildenafilheterologo2)

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Sildenafilstructure (Sildenafilstructure)
Chemical structure of Sildenafil depicted in a molecular diagram showing its key functional groups and ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.